Klaassen, Ingeborg http://orcid.org/0000-0003-1695-9403
Avery, Peter
Schlingemann, Reinier O.
Steel, David H. W.
Funding for this research was provided by:
Stichting Blinden-Penning (UitZicht 2017-30, UitZicht 2017-30)
Rotterdamse Stichting Blindenbelangen (B20170068, B20170068)
Nederlandse Vereniging ter Verbetering van het Lot der Blinden
Stichting Blindenhulp
Edward and Marianne Blaauw Fund for Ophthalmology
Bayer Pharmaceuticals (IIR-GB-2016-2886, IIR-GB-2016-2886)
Article History
Received: 2 August 2022
Accepted: 28 November 2022
First Online: 6 December 2022
Competing interests
: The study was supported in part by a grant from Bayer pharmaceuticals to Newcastle University, but the company did not a role in study design or interpretation and did not have any editorial control over the content of the final manuscript.